Interference of Blood Cell Lysis on Routine Coagulation Testing
Open Access
- 1 February 2006
- journal article
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 130 (2) , 181-184
- https://doi.org/10.5858/2006-130-181-iobclo
Abstract
Context.—Preanalytical factors influencing the reliability of laboratory testing are commonplace. It is traditionally accepted that hemolytic samples are unsuitable for coagulation assays because of the release of hemoglobin, intracellular components, and thromboplastic substances from damaged blood cells. Objective.—To evaluate the influence of blood cell lysis on routine coagulation testing. Design.—Twelve aliquots prepared by serial dilutions of homologous lysated samples collected from 10 different subjects, and displaying a final percentage of lysis ranging from 0% to 9.1%, were tested for prothrombin time, activated partial thromboplastin time, fibrinogen, and dimerized plasmin fragment D. Lysis was achieved by subjecting citrated whole blood to a freeze-thaw cycle. Outcome Measures.—Interference from blood cell lysis on routine coagulation testing. Results.—Statistically significant increases in prothrombin time and dimerized plasmin fragment D were observed in samples containing final lysate concentrations of 0.5% and 2.7% respectively, whereas significant decreases were observed in activated partial thromboplastin time and fibrinogen in samples containing a final lysate concentration of 0.9%. The current analytical quality specifications for desirable bias are ±2.0% for prothrombin time, ±2.3% for activated partial thromboplastin time, and ±4.8% for fibrinogen. Percent variations from the baseline values exceeding the current analytical quality specifications for desirable bias were achieved for lysate concentrations of 0.9% (prothrombin time and activated partial thromboplastin time) and 1.8% (fibrinogen), corresponding to average free plasma hemoglobin concentrations of 1.7 and 3.4 g/L, respectively. Conclusion.—Our results confirm that, although slightly hemolyzed specimens might still be analyzable, a moderate blood cell lysis, as low as 0.9%, influences the reliability of routine coagulation testing. Because the interference in coagulation assays has a wide interindividual bias, we do not recommend lysis correction and we suggest that the most appropriate corrective measure should be free hemoglobin quantification and sample recollection.Keywords
This publication has 13 references indexed in Scilit:
- The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma HemoglobinJAMA, 2005
- Physician Survey of a Laboratory Medicine Interpretive Service and Evaluation of the Influence of Interpretations on Laboratory Test OrderingArchives of Pathology & Laboratory Medicine, 2004
- Effect of Specimen Collection on Routine Coagulation Assays and D-Dimer MeasurementClinical Chemistry, 2004
- Oral Anticoagulant Monitoring by Laboratory or Near-Patient Testing: What a Clinician Should Be Aware OfSeminars in Vascular Medicine, 2003
- Rejection of specimens for prothrombin time and relating pre-analytical factors in blood collectionBlood Coagulation & Fibrinolysis, 2002
- Hemolysis in Serum Samples Drawn by Emergency Department Personnel versus Laboratory PhlebotomistsLaboratory Medicine, 2002
- Preanalytical aspects of routine coagulation measurementsScandinavian Journal of Clinical and Laboratory Investigation, 2001
- Current databases on biological variation: pros, cons and progressScandinavian Journal of Clinical and Laboratory Investigation, 1999
- Effect of in Vitro Hemolysis on 25 Common Biochemical TestsClinical Chemistry, 1992
- The Effects of 0.1 and 1.0 PerCent Erythrocytes and Hemolysis on Serum Chemistry ValuesAmerican Journal of Clinical Pathology, 1976